Carolyn D. Dzierba - Concepedia

Author

Carolyn D. Dzierba

Bristol-Myers Squibb (United States)ORCID

Also Known As

C D Dzierba, C. D. DZIERBA, Carolyn D Dzierba, Carolyn D. Dzierba, Carolyn Dzierba

Publications

789

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Lexicon Pharmaceuticals (United States)Biocon (India)Bristol-Myers Squibb (India)Bristol-Myers Squibb (Germany)

About

Carolyn D. Dzierba is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	136
2	Biochemistry	5	5	135
3	Natural Sciences	4	4	106
4	Engineering	2	2	283
5	Biomolecular Engineering	1	1	235

Carolyn D. Dzierba

Publications

711

Citations

H-Index

Page 1

	Year	Citations
Ti-Catalyzed Enantioselective Addition of Cyanide to Imines. A Practical Synthesis of Optically Pure α-Amino Acids Clinton A. Krueger, Kevin W. Kuntz, Carolyn D. Dzierba, Journal of the American Chemical Society EngineeringA Practical SynthesisAltmetric Attention ScoreOrganic ChemistrySocial Media Presence	1999	235
Inhibition of AAK1 Kinase as a Novel Therapeutic Approach to Treat Neuropathic Pain Walter A. Kostich, Brian D. Hamman, S. Naidu, Journal of Pharmacology and Experimental Therapeutics	2016	118
An Ascending Synthesis of Adrenalcorticosteroids. The Total Synthesis of (+)-Adrenosterone Carolyn D. Dzierba, Kathleen S. Zandi, Thomas M. J. Möllers, Journal of the American Chemical Society Adrenal GlandBiosynthesisEngineeringBiochemistryNatural Sciences	1996	48
Development of New Benzenesulfonamides As Potent and Selective Na<sub>v</sub>1.7 Inhibitors for the Treatment of Pain Yong‐Jin Wu, Jason Guernon, Jianliang Shi, Journal of Medicinal Chemistry	2017	36
<i>In vitro</i> Characterization of a small molecule inhibitor of the alanine serine cysteine transporter ‐1 (<scp>SLC</scp>7A10) Jeffrey M. Brown, Lisa Hunihan, M M Prack, Journal of Neurochemistry Molecular PharmacologyInhibitory ActivityNmda Receptor HypofunctionBiochemistryFunctional Selectivity	2013	30
Design, synthesis, and evaluation of phenylglycinols and phenyl amines as agonists of GPR88 Carolyn D. Dzierba, Yingzhi Bi, Bireshwar Dasgupta, Bioorganic & Medicinal Chemistry Letters Combinatorial ChemistryMolecular PharmacologyBiochemistryMedicinePhenyl Amines	2015	29
The discovery of potent agonists for GPR88, an orphan GPCR, for the potential treatment of CNS disorders Yingzhi Bi, Carolyn D. Dzierba, Cynthia A. Fink, Bioorganic & Medicinal Chemistry Letters Cns DisordersG Protein-coupled ReceptorMedicineFunctional SelectivityPotent Agonists	2015	28
Discovery of Indole- and Indazole-acylsulfonamides as Potent and Selective Na<sub>V</sub>1.7 Inhibitors for the Treatment of Pain Guanglin Luo, Ling Chen, Amy Easton, Journal of Medicinal Chemistry	2018	28
Discovery of (<i>S</i>)-1-((2′,6-Bis(difluoromethyl)-[2,4′-bipyridin]-5-yl)oxy)-2,4-dimethylpentan-2-amine (BMS-986176/LX-9211): A Highly Selective, CNS Penetrable, and Orally Active Adaptor Protein-2 Associated Kinase 1 Inhibitor in Clinical Trials for the Treatment of Neuropathic Pain Guanglin Luo, Ling Chen, Walter A. Kostich, Journal of Medicinal Chemistry	2022	27
Small Molecule Receptor Protein Tyrosine Phosphatase γ (RPTPγ) Ligands That Inhibit Phosphatase Activity via Perturbation of the Tryptophan–Proline–Aspartate (WPD) Loop S. Sheriff, Brett R. Beno, Weixu Zhai, Journal of Medicinal Chemistry	2011	21

Page 1